FIGURE

Figure 5

ID
ZDB-FIG-220426-98
Publication
Lane et al., 2021 - Steroid-sensitive nephrotic syndrome candidate gene CLVS1 regulates podocyte oxidative stress and endocytosis
Other Figures
All Figure Page
Back to All Figure Page
Figure 5

CLVS1 is required for clathrin-mediated endocytosis in human podocytes.

To examine specific modes of endocytosis in CLVS1 podocytes, we evaluated the internalization of fluorescently labeled transferrin (clathrin-mediated endocytosis), 70,000 MW dextran (macropinocytosis), and albumin molecules (caveolae-mediated endocytosis). (A and B) Quantification of the number of internalized transferrin molecules per cell revealed a decrease in clathrin-mediated endocytosis in CLVS1-KO and homozygous H310Y-KI podocytes compared with controls that was unaffected by pretreatment with 1 μM dexamethasone. (n > 30 for each group, P < 0.0001, 1-way ANOVA.) (C and D) Macropinocytosis, as measured by the internalization of fluorescently labeled 70,000 MW dextran molecules, was unaffected by CLVS1 KO or H310Y KI (P = 0.9572 and P = 0.9604 respectively, 1-way ANOVA). However, treatment with dexamethasone did significantly increase macropinocytosis in all cell lines compared with vehicle-treated controls (P < 0.001 for all). (E and F) Caveolae-mediated endocytosis was comparable among CLVS1-KO, homozygous H310Y-KI podocytes, and controls when internalized albumin molecules were quantified, and this was unaffected by treatment with dexamethasone (n > 30 for each group, P = 0.993 and P = 0.1844 respectively, 1-way ANOVA). Error bars depict SEM in graphs. Scale bars = 12 μm. Each dot in the graphs represents the mean number of molecules per podocyte for a single well.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ JCI Insight